Management of anterior chamber dislocation of a dexamethasone intravitreal implant: A case report

被引:0
|
作者
Pacella F. [1 ]
Agostinelli E. [2 ]
Carlesimo S.C. [1 ]
Nebbioso M. [1 ]
Secondi R. [1 ]
Forastiere M. [1 ]
Pacella E. [1 ]
机构
[1] Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Viale del Policlinico, Rome
[2] Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome
关键词
Case report; Cystoid macular edema; Intravitreal dexamethasone implant; Ozurdex; Ozurdex dislocation;
D O I
10.1186/s13256-016-1077-2
中图分类号
学科分类号
摘要
Background: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be managed by repositioning the implant into the vitreous cavity. We describe the case of a successful repositioning of an Ozurdex implant by mobilization and subsequent balanced saline solution injection in the anterior chamber. Case presentation: An 83-year-old white woman presented to our Emergency Unit complaining of pain and vision loss in herright eye lasting a week. Her anamnesis revealed a history of persistent cystoid macular edema after phacoemulsification with scleral-fixated posterior chamber intraocular lens implantation, recently treated with an intravitreal Ozurdex implant. She also took a long-distance flight 2 days after the injection. An anterior segment examination showed corneal edema and the rod implant adherent to corneal endothelium. To avoid corneal decompensation, we opted for a implant repositioning. Under topical anesthesia, a 30-gauge needle was introduced through a limbar incisionto mobilize the dislocated rod. Balanced saline solution was injected, with a successful repositioning of the implant into the vitreous cavity. Topical 5 % hypertonic saline solution and 0.2 % betamethasone associated with 0.5 % chloramphenicol drops were administered four times a day. To prevent redislocation of the Ozurdex implant, she was instructed to avoid prone position, any kind of physical effort, and not to undertake long-distance flights during the first postoperative week. One week after surgery, an anterior segment examination showed an improvement of corneal edema. Funduscopy showed that the Ozurdex implant was settled into the vitreous cavity. Conclusions: Anterior chamber dislocation of Ozurdex from the vitreous cavity is rare. In our patient, in addition to the posterior capsule tearing, the long-distance flight could have contributed to implant dislocation. Repositioning of the implant is necessary to avoid endothelial decompensation. It can be carried out by using saline balanced solution with the same efficacy as other surgical procedures reported in the literature. A possible disadvantage of this procedure could be implant migration. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Anterior Chamber Migration of Intravitreal Dexamethasone Implant in an Eye with Scleral-fixated Intraocular Lens
    Goel, Neha
    Mehta, Aanchal
    Batra, Jyoti
    Choudhry, Reena
    JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2020, 15 (04) : 581 - 583
  • [22] Late Migration of Dexamethasone Implant Into Anterior Chamber
    Cronin, Kevin M.
    Govind, Kishan
    Kurup, Shree K.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (06) : 711 - 711
  • [23] Anterior vitreous displacement of the intravitreal dexamethasone implant (Ozurdex)
    Ch'ng, S. Wai
    Padroni, S.
    Banerjee, S.
    EYE, 2014, 28 (02) : 238 - 239
  • [24] Anterior vitreous displacement of the intravitreal dexamethasone implant (Ozurdex)
    S Wai Ch'ng
    S Padroni
    S Banerjee
    Eye, 2014, 28 : 238 - 239
  • [25] Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens
    Stavrakas, Panagiotis
    Gartaganis, Panos
    Totou, Styliani
    Chalkiadaki, Evangelia
    Manousakis, Evangelos
    Karmiris, Efthymios
    CASE REPORTS IN OPHTHALMOLOGY, 2023, 14 (01): : 229 - 233
  • [26] Acute Bacterial Endophthalmitis Following Dexamethasone Intravitreal Implant: A Case Report
    Al Zamil, Waseem
    Yassin, Sanaa A.
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2019, 7 (02): : 110 - 113
  • [27] Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report
    Ekinci, Cansu
    Kayiran, Alp
    Ozdemir, Hakan
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2019, 49 (03): : 175 - 177
  • [28] Anterior Chamber Migration of Fluocinolone Acetonide Intravitreal Implant
    Rishi, Pukhraj
    Majumder, Parthopratim Dutta
    Biswas, Jyotirmay
    JAMA OPHTHALMOLOGY, 2019, 137 (09)
  • [29] Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient
    Stepanov, Alexandr
    Codenotti, Marco
    Ramoni, Andrea
    Prati, Matteo
    Jiraskova, Nada
    Rozsival, Pavel
    Bandello, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (03) : E52 - E54
  • [30] The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (OzurdexA®)
    Kang, Hyunseung
    Lee, Min Woo
    Byeon, Suk Ho
    Koh, Hyoung Jun
    Lee, Sung Chul
    Kim, Min
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (09) : 1819 - 1825